Literature DB >> 3134853

Treatment of experimental Salmonella typhimurium infection in mice with fleroxacin.

T Butler, M R Jacobs, D Farhi.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3134853      PMCID: PMC172279          DOI: 10.1128/AAC.32.5.791

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


× No keyword cloud information.
  9 in total

1.  Pharmacokinetics and tissue penetration of Ro 23-6240, a new trifluoroquinolone.

Authors:  R Wise; B Kirkpatrick; J Ashby; D J Griggs
Journal:  Antimicrob Agents Chemother       Date:  1987-02       Impact factor: 5.191

2.  In vitro activity of Ro 23-6240, a new fluorinated 4-quinolone.

Authors:  N X Chin; D C Brittain; H C Neu
Journal:  Antimicrob Agents Chemother       Date:  1986-04       Impact factor: 5.191

3.  Therapy of antimicrobial-resistant typhoid fever.

Authors:  T Butler; N N Linh; K Arnold; M D Adickman; D M Chau; M M Muoi
Journal:  Antimicrob Agents Chemother       Date:  1977-04       Impact factor: 5.191

4.  Effect of a Salmonella group H1 R factor on virulence and response of infections to antimicrobial therapy.

Authors:  T Butler; C W Shuster; A Franco
Journal:  Antimicrob Agents Chemother       Date:  1979-03       Impact factor: 5.191

5.  Uptake of ciprofloxacin by human neutrophils.

Authors:  C S Easmon; J P Crane
Journal:  J Antimicrob Chemother       Date:  1985-07       Impact factor: 5.790

6.  Ciprofloxacin treatment of systemic salmonella infection in sensitive and resistance mice.

Authors:  C S Easmon; A Blowers
Journal:  J Antimicrob Chemother       Date:  1985-11       Impact factor: 5.790

7.  Uptake of ciprofloxacin by macrophages.

Authors:  C S Easmon; J P Crane
Journal:  J Clin Pathol       Date:  1985-04       Impact factor: 3.411

8.  Single- and multiple-dose pharmacokinetics of fleroxacin, a trifluorinated quinolone, in humans.

Authors:  E Weidekamm; R Portmann; K Suter; C Partos; D Dell; P W Lücker
Journal:  Antimicrob Agents Chemother       Date:  1987-12       Impact factor: 5.191

9.  In vitro and in vivo antibacterial activity of AM-833, a new quinolone derivative.

Authors:  K Hirai; H Aoyama; M Hosaka; Y Oomori; Y Niwata; S Suzue; T Irikura
Journal:  Antimicrob Agents Chemother       Date:  1986-06       Impact factor: 5.191

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.